Futilimab

Futilimab is a monoclonal antibody indicated in the treatment of metastatic cancer complicated by septic shock, multi-organ system failure, and death. The drug costs about $4,000,000,000 per infusion, is infused rectally over 35 days, and extends life-expectancy by an average of 3 minutes. When used with hospicillin, the effects of futilimab are synergistic.

Related Topics

---

• Back Compression
• Clutch
• Death
• DNR
• ECOG Score
• Postmortem Antibiotics

References

---

Fun Stuff

---

Try a random entry. OR 

Share

this post with your friends

Random Gomerpedia Entries

---

• Water Pill
• According to the Literature
• Roy Moore
• Pick Your Brain
• Colonel Conscious Sedation

Need More Gomer?

---

• Gomerapp
  
• Gomerblog

---